Financial statements Genex Lab
Balance sheet of Genex Lab
Company age:
Age:
5 y. 4 m. 14 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of GENEX LAB
|
Year
|
2020
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 5 789,58 | 2 584,89 | 3 593,42 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 |
| B. Current assets | 5 789,58 | 2 584,89 | 3 593,42 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 5 789,58 | 2 584,89 | 3 593,42 |
| A. Equity | 543,58 | -3 153,11 | -11 527,63 |
| B. Liabilities and provisions for liabilities | 5 246,00 | 5 738,00 | 15 121,05 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 5 246,00 | 5 738,00 | 15 121,05 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.